PARIS - 8 February 2019 - After several years of research and development, the start-up Enovap, incubated at the Technopole of Aube in Champagne, launches on the market the first personal intelligent vaporizer of nicotine management. Available at the price of 129 € TTC on the site of the brand and 200 shops in France, this device gives control to its user, thus offering a real innovative experience to get rid of tobacco and nicotine.
AN INNOVATION THAT RESPONDS TO A DOUBLE CHALLENGE!
According to a study conducted by researchers at Queen Mary University London published the January 30 2019 in the New England Journal of Medicine1 the electronic cigarette is twice as effective as conventional nicotine substitutes (patch, sucking tablet, chewing gum ...) as part of a smoking cessation. Indeed, one year after the start of weaning, 18% of patients who stopped smoking with the help of the electronic cigarette are still abstinent, against only 9,9% of people who stopped with the help of a conventional nicotine replacement. However, this study notes that 80% of people who have weaned tobacco still use their electronic cigarette and are by definition still dependent on nicotine. Thanks to its double reservoir and its artificial intelligence, Enovap fully meets this double challenge: that of smoking cessation and nicotine.